4-Benzyl-1-(oxolan-2-ylmethyl)-2-sulfanyl-4,5-dihydro-1H-imidazol-5-one

Catalog No. :
ACNKJB643
CAS No. :
1008698-17-6
Molecular Formula :
C15H18N2O2S
Molecular Weight :
290.39

IUPAC Name:5-benzyl-2-mercapto-3-((tetrahydrofuran-2-yl)methyl)-3,5-dihydro-4H-imidazol-4-one

4-Benzyl-1-(oxolan-2-ylmethyl)-2-sulfanyl-4,5-dihydro-1H-imidazol-5-one structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg98%$70.00Login to see priceInquiryInquiry
100mg98%$100.00Login to see priceInquiryInquiry
250mg98%$131.00Login to see priceInquiryInquiry
1g98%$336.00Login to see priceInquiryInquiry
5g98%$943.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name4-Benzyl-1-(oxolan-2-ylmethyl)-2-sulfanyl-4,5-dihydro-1H-imidazol-5-one
IUPAC Name5-benzyl-2-mercapto-3-((tetrahydrofuran-2-yl)methyl)-3,5-dihydro-4H-imidazol-4-one
MDL No.MFCD03982025
Molecular FormulaC15H18N2O2S
Molecular Weight290.39
SMILESO=C1C(CC2=CC=CC=C2)N=C(S)N1CC3OCCC3
InChI KeyXSSWEDXLBHLXJT-UHFFFAOYSA-N
Synonym4-Imidazolidinone, 5-(phenylmethyl)-3-[(tetrahydro-2-furanyl)methyl]-2-thioxo-;5-(Phenylmethyl)-3-[(tetrahydro-2-furanyl)methyl]-2-thioxo-4-imidazolidinone;4-Benzyl-1-(oxolan-2-ylmethyl)-2-sulfanyl-4,5-dihydro-1H-imidazol-5-one
CAS No.1008698-17-6

Synthetic Route by SureRoute

1. ACNKJB643 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNKJB643 route product structure diagram
    ACNKJB6431008698-17-6
Inquiry

2. ACNKJB643 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACNKJB643 route product structure diagram
    ACNKJB6431008698-17-6
Inquiry

Comments (0)